Agilent Presents Solutions Innovation Research Awards to Institut National de la Recherche Scientifique and University of Southern California Scientists
Agilent Technologies (NYSE: A) has awarded its Solutions Innovation Research Award (SIRA) to Professor Isabelle Plante from INRS and Professor Bangyan Stiles from USC for their cell and gene therapy research. Professor Plante's research focuses on breast cancer mechanisms and environmental pollutants, while Professor Stiles studies lipid metabolic dysfunction in cancer formation. Both recipients will receive one-year loans of various Agilent instruments including the NovoCyte Penteon flow cytometer. The SIRA initiative, established in 2023, aims to support innovative academic research using Agilent's analytical solutions.
Agilent Technologies (NYSE: A) ha conferito il suo Premio per l'Innovazione nelle Soluzioni di Ricerca (SIRA) alla Professoressa Isabelle Plante dell'INRS e al Professore Bangyan Stiles della USC per la loro ricerca sulla terapia cellulare e genica. La ricerca della Prof.ssa Plante si concentra sui meccanismi del cancro al seno e sui contaminanti ambientali, mentre il Prof. Stiles studia la disfunzione lipidica nel processo di formazione del cancro. Entrambi i destinatari riceveranno prestiti di un anno di vari strumenti Agilent, incluso il citometro a flusso NovoCyte Penteon. L'iniziativa SIRA, istituita nel 2023, ha l'obiettivo di supportare la ricerca accademica innovativa utilizzando le soluzioni analitiche di Agilent.
Agilent Technologies (NYSE: A) ha otorgado su Premio de Innovación en Investigación de Soluciones (SIRA) a la Profesora Isabelle Plante del INRS y al Profesor Bangyan Stiles de la USC por su investigación en terapia celular y génica. La investigación de la Profesora Plante se centra en los mecanismos del cáncer de mama y contaminantes ambientales, mientras que el Profesor Stiles estudia la disfunción metabólica lipídica en la formación del cáncer. Ambos beneficiarios recibirán préstamos de un año de varios instrumentos de Agilent, incluido el citómetro de flujo NovoCyte Penteon. La iniciativa SIRA, establecida en 2023, tiene como objetivo apoyar la investigación académica innovadora utilizando las soluciones analíticas de Agilent.
Agilent Technologies (NYSE: A)는 솔루션 혁신 연구 상(SIRA)을 INRS의 이자벨 플란트 교수와 USC의 방얀 스타일스 교수에게 세포 및 유전자 치료 연구에 대해 수여했습니다. 플란트 교수의 연구는 유방암 메커니즘과 환경 오염물질에 초점을 맞추고 있으며, 스타일스 교수는 암 형성에서 지질 대사 기능 장애를 연구합니다. 두 수상자는 NovoCyte Penteon 유세포 분석기를 포함한 다양한 Agilent 기기의 1년 대여를 받을 것입니다. 2023년에 설립된 SIRA 이니셔티브는 Agilent의 분석 솔루션을 사용한 혁신적인 학술 연구를 지원하는 것을 목표로 합니다.
Agilent Technologies (NYSE: A) a décerné son Prix d'Innovation en Recherche de Solutions (SIRA) à la Professeure Isabelle Plante de l'INRS et au Professeur Bangyan Stiles de l'USC pour leurs recherches sur la thérapie cellulaire et génique. Les recherches de la Professeure Plante portent sur les mécanismes du cancer du sein et les polluants environnementaux, tandis que le Professeur Stiles étudie la dysfonction métabolique des lipides dans la formation du cancer. Les deux lauréats recevront des prêts d'un an de divers instruments Agilent, y compris le cytomètre en flux NovoCyte Penteon. L'initiative SIRA, créée en 2023, vise à soutenir la recherche académique innovante utilisant les solutions analytiques d'Agilent.
Agilent Technologies (NYSE: A) hat den Solutions Innovation Research Award (SIRA) an Professorin Isabelle Plante von der INRS und Professor Bangyan Stiles von der USC für ihre Forschung zur Zell- und Gentherapie verliehen. Die Forschung von Professorin Plante konzentriert sich auf die Mechanismen von Brustkrebs und Umweltverschmutzung, während Professor Stiles die lipidmetabolische Dysfunktion bei der Krebsentstehung untersucht. Beide Preisträger erhalten einjährige Darlehen verschiedener Agilent-Geräte, einschließlich des NovoCyte Penteon Flusszytometers. Die SIRA-Initiative, die 2023 ins Leben gerufen wurde, zielt darauf ab, innovative akademische Forschung unter Verwendung von Agilents analytischen Lösungen zu unterstützen.
- Strategic expansion into cell and gene therapy research through equipment loans
- Strengthening academic partnerships in emerging healthcare technologies
- Building presence in personalized medicine market
- None.
Professor Isabelle Plante and Professor Bangyan Stiles recognized for their revolutionary work in cell and gene therapy research
Developing new cell and gene therapies is increasingly vital amid the heightened focus on personalized treatments in the healthcare industry. In recognition of this growing need, Agilent will grant two SIRA awards to support and encourage research to drive critical breakthroughs in cell and gene therapy.
“We are thrilled to recognize the groundbreaking research of Professor Isabelle Plante and Professor Bangyan Stiles with an Agilent Solutions Innovation Research Award,” said Nahid Chalyavi, associate vice president of University Relations and External Research at Agilent. “Their work in cell and gene therapy is paving the way for significant advancements in personalized medicine. At Agilent, we are committed to supporting innovative research that addresses critical scientific challenges and drives the future of healthcare.”
Professor Plante is a Professor at INRS and the Director and Co-founder of the Intersectoral Centre for Endocrine Disruptor Analysis (ICEDA) research network. Her work aims to understand the biology of the breast and the mechanisms that lead to breast cancer, particularly after exposure to environmental pollutants. To achieve this, Professor Plante has developed a platform of models for fundamental and toxicological research, and for evaluating the effects of therapeutic agents on the breast. The study involves using proteomic, transcriptomic, and functional analysis to assess the impacts of pollutants or therapeutic molecules combined with imaging. Professor Plante will receive a one-year loan of Agilent NovoCyte Penteon, BioTek Cytation 5, and xCelligence instruments as part of the award.
“On average, 15 women lose their lives to breast cancer each day. While the exact causes of breast cancer remain largely unknown, a growing body of epidemiological and laboratory evidence suggests that exposure to environmental pollutants increases the risk. Given the vast number of potentially carcinogenic molecules present in our environment, there is an urgent need to develop biologically relevant models for rapid risk assessment and to explore new therapeutic avenues,” stated Professor Plante. “We extend our heartfelt thanks to Agilent for this invaluable opportunity to co-develop new models and methodologies that will help prevent and treat breast cancer, potentially saving many lives.”
Professor Stiles is the Boyd P. and Elsie D. Welin Professor of Pharmaceutical Sciences in the Department of Pharmacology and Pharmaceutical Sciences at USC Mann. Her work focuses on understanding how lipid metabolic dysfunction contributes to cancer formation, using hepatocellular carcinoma as a model, indicates that fat accumulation is necessary for tumor growth. Professor Stiles’ lab utilizes molecular biology and genetics tools, including Chip-seq and RNA-seq, to investigate the molecular signals driving this process. As part of Professor Stiles’ award, the lab will receive a one-year loan of an Agilent NovoCyte Penteon flow cytometer.
“I am deeply honored to receive the Agilent Solutions Innovation Research Award, which supports our lab’s mission to understand how lipid metabolic dysfunction contributes to cancer formation,” stated Professor Stiles. “Our work, using hepatocellular carcinoma as a model, has shown that fat accumulation is critical for tumor growth. With the loan of an Agilent NovoCyte Penteon flow cytometer, we’re now equipped to explore the cellular components in the tumor microenvironment that are responsible for how fat accumulation contribute to cancer growth. This award strengthens our commitment to pioneering research that could lead to transformative treatments in personalized medicine.”
Established in 2023, the Agilent SIRA initiative aims to stimulate innovative and impactful use of Agilent products to help solve pressing scientific problems in academia. The awards reinforce Agilent’s commitment to facilitating university research and increasing awareness of and access to its portfolio of analytical solutions.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of
View source version on businesswire.com: https://www.businesswire.com/news/home/20241106140731/en/
Media Contact
Naomi Goumillout
Agilent Technologies
+1.978.314.1862
naomi.goumillout@agilent.com
Source: Agilent Technologies Inc.
FAQ
What is Agilent's SIRA award and who won it in 2023?
What equipment is Agilent (NYSE: A) providing to SIRA winners?
When did Agilent Technologies establish the SIRA initiative?
